ArticleImmunity, inflammation and disease2023

The CD2-CD58 axis: A novel marker predicting poor prognosis in patients with low-grade gliomas and potential therapeutic approaches.

Mingwei Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.